Codexis

CDXS

Last Price
04/24/26, 09:30 AM
 EDT
$
2.62
(
4.0
%)
(
+
4.0
%)
Margin of Safety
+
22.5
%
Modeled Fair Value
$
3.21
Modeled Fair Value
$336 million
Allocation Group
Future Compounder
Allocation Tier
Coming soon!

Investment Thesis

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
An icon graphic of Gouldy the Finch.
#protectYourAssets

Solt DB will launch asset deep dives for all companies in the coverage ecosystem by the end of 2026. These will seamlessly integrate into company-specific financial models, allowing members to determine a company's fair value when specific assets are included or excluded.

Want me to prioritize a specific company or asset? Let me know on Discord or through the contact page.

Last Refined

March 15, 2026
The current model INCLUDES the following assets and assumptions:
The current model is based on operating metrics, including:
    • The Heritage Business has an estimated value of $124.58 million, revised from a previous estimate of $85.8 million. The change reflects full-year 2026 revenue that's much higher than prior estimates. As ECO Synthesis begins contributing meaningful revenue this year, it will be more difficult to gauge the health of the legacy segment unless the company provides detailed financials.
    • The Heritage Business can return to growth beginning in 2028 if customer assets in pivotal studies earn approvals. Three such assets had data readouts in recent months with two claiming success, which leaves the pipeline with 11 more customer assets. Every approval represents a multi-year revenue stream.
    • The ECO Synthesis platform is valued at $197 million, revised from a previous estimate of $233 million. The revision more accurately reflects guidance for the GMP facility to be fully operational by the end of 2027 (later than expected). This component can become more valuable if ligation services ramp in 2026.
The current model EXCLUDES the following assets:

SEC Filings